Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Johnson

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|September 14, 2018
Metformin as a Therapeutic Target in Endometrial CancersTeresa Y Lee, Ubaldo E Martinez-Outschoorn, Russell J Schilder, et al.
BMJ Open|July 21, 2022
Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocolAmy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
Clinics and Practice|September 22, 2022
Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer CentersZachary T Elliott, Zachary Goldberg, Ramez Philips, et al.
Journal of Thyroid Disorders & Therapy|May 24, 2016
Thyroid Cancer Metabolism: A ReviewKurren S Gill, Patrick Tassone, James Hamilton, et al.
Frontiers in Oncology|July 11, 2022
Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract CancersMarina Domingo-Vidal, Diana Whitaker-Menezes, Mehri Mollaee, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Single institution implementation of permanent <sup>131</sup>Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinomaVoichita Bar-Ad, Emily Hubley, Adam Luginbuhl, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2023
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckAyesha S Ali, Gregor Manukian, Jennifer M Johnson, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Scientific Reports|December 19, 2019
Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynxAndrew P South, Nicoline Y den Breems, Tony Richa, et al.
Plos Computational Biology|June 3, 2025
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|September 14, 2018
Metformin as a Therapeutic Target in Endometrial CancersTeresa Y Lee, Ubaldo E Martinez-Outschoorn, Russell J Schilder, et al.
BMJ Open|July 21, 2022
Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocolAmy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
Clinics and Practice|September 22, 2022
Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer CentersZachary T Elliott, Zachary Goldberg, Ramez Philips, et al.
Journal of Thyroid Disorders & Therapy|May 24, 2016
Thyroid Cancer Metabolism: A ReviewKurren S Gill, Patrick Tassone, James Hamilton, et al.
Frontiers in Oncology|July 11, 2022
Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract CancersMarina Domingo-Vidal, Diana Whitaker-Menezes, Mehri Mollaee, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Single institution implementation of permanent <sup>131</sup>Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinomaVoichita Bar-Ad, Emily Hubley, Adam Luginbuhl, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2023
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckAyesha S Ali, Gregor Manukian, Jennifer M Johnson, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Scientific Reports|December 19, 2019
Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynxAndrew P South, Nicoline Y den Breems, Tony Richa, et al.
Plos Computational Biology|June 3, 2025
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Pageof 9